AngioDynamics
ANGO
162 hedge funds and large institutions have $493M invested in AngioDynamics in 2026 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 55 increasing their positions, 56 reducing their positions, and 15 closing their positions.
1,856% more call options, than puts
Call options by funds: $176K | Put options by funds: $9K
107% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 15
13% more capital invested
Capital invested by funds: $438M → $493M (+$55.2M)
10% more funds holding
Funds holding: 147 → 162 (+15)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 56
1.65% less ownership
Funds ownership: 93.56% → 91.92% (-1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$5.02M |
| 2 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$4.41M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$3.84M |
| 4 |
AC
Armistice Capital
New York
|
+$3.74M |
| 5 |
JP Morgan Chase
New York
|
+$2.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$6.39M |
| 2 |
BAM
Bastion Asset Management
Montreal,
Canada
|
-$4.44M |
| 3 |
State Street
Boston,
Massachusetts
|
-$4.28M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.5M |
| 5 |
BH
Broadfin Holdings
Melville,
New York
|
-$2.85M |
ANGO Hedge Fund Activity: Q2 2026 in Review
162 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2026, worth a combined $493M — up 13% from $438M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ANGO positions and 15 closed out — a net gain of 16 holders — while 55 added to existing stakes and 56 trimmed.
The largest buyer was Royce & Associates, adding an estimated $5.02M. The largest seller was Divisadero Street Capital Management, exiting entirely with an estimated $6.39M sold.
- 162 institutional investors held AngioDynamics (ANGO) as of Q2 2026, up from 147 in Q1 2026.
- Funds reported $493M of AngioDynamics stock for Q2 2026, up 13% quarter-over-quarter.
- 31 funds opened new AngioDynamics positions in Q2 2026 and 15 closed out, a net change of +16 holders.
- The largest AngioDynamics buyer in Q2 2026 was Royce & Associates, an estimated $5.02M added.
- The largest AngioDynamics seller in Q2 2026 was Divisadero Street Capital Management, an estimated $6.39M sold.
Based on aggregated 13F filings for Q2 2026.